(ID 177520873 © Rik Trottier | Dreamstime.com)

By paNOW Staff

Province reports 829 laboratory confirmed cases of COVID-19 and 14 deaths in weekly report

Apr 28, 2022 | 2:04 PM

The provincial government is reporting another 829 new cases of COVID last week as part of their epidemiology (epi) report released today. This is a slight drop compared to last week’s report of 889 confirmed cases.

Also included were reports of 14 new COVID-19 related deaths of Saskatchewan residents, a drop from last weeks report of 20 deaths.

The number of tests performed was also lower than the number of tests in the previous week with 6,951 performed compared to 7,354.

During the two months period from February 13 to April 16, 2022, the risk of hospitalization, ICU admission and death was five, nine and seven times higher respectively among unvaccinated individuals compared to those vaccinated with three doses.

There were 44.4 COVID-like illness patients per 1,000 emergency department visits which was higher than the average weekly rate in the previous six weeks (34.4 per week/1,000 visits).

Riderville

A LOT Going on This Week

11h ago

SHEEP TALK

New 4-H sheep club in Makwa offers hands-on experience in sheep raising

Nov 04, 2024

Four people injured in rollover near Onion Lake

Nov 04, 2024

There were 22 confirmed COVID-19 outbreaks in long-term care and care home settings also reported this week.

As of April 23, 2022, of the population five years and older, 85.8 per cent received at least one dose of a two-dose COVID-19 vaccine and 80.8 per cent completed a series.

Among the population 18 years and older, 51.8 per cent had received at least one booster vaccination.

The Saskatchewan Health Authority will also be expanding their Paxlovid eligibility requirements.

Effective immediately, eligibility for Paxlovid treatment will be extended to all those who test positive (PCR or rapid test) with mild or moderate COVID-19 symptoms who are immunocompromised or 70 years and older with designated risk factors, regardless of vaccination status.

This is in addition to adults who are 18-54 years of age and are not fully vaccinated with a medical condition that puts them at high risk for severe outcomes, or are 55 to 69 years of age and are not fully vaccinated.

Even with the expanding of this treatment option, the health authority still encourages members of the public to get their vaccinations as the best way of fighting COVID-19.

The provincial supply of AstraZeneca vaccine expires as of April 30 and the Government of Canada will not be securing additional doses.

If you are seeking AstraZeneca to complete your primary, two dose vaccination series or for a booster dose, contact 1-833-SaskVax (727-5829) to book your appointment immediately.

Note that all of the vaccines being administered are effective and approved by Health Canada for use and NACI has approved the interchangeability of COVID-19 vaccines authorized for use in Canada. Anyone who received AstraZeneca is eligible to receive an mRNA or protein-based vaccine for additional doses to ensure optimal protection against COVID-19, unless contraindicated.

–

panews@pattisonmedia.com

On Twitter: @princealbertnow